Key Insights

Highlights

Treatment Research

3 treatments under study, led by Single Fraction Radiation

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00984165Phase 2Terminated

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Showing all 1 trials

Research Network

Common Treatments

  • Single Fraction Radiation1
  • Donor Lymphocyte Infusion Dli1
  • Apheresis1

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Nonhodgkins Lymphoma1
  • Chronic Lymphocytic Leukemias1
  • Hodgkins Lymphoma1

Activity Timeline